Back

Dynamic risk assessment of severe ventricular arrhythmia in patients with implantable defibrillators and reduced left ventricular ejection fraction

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Diagnostic methods in ventricular arrhythmias (1) Diagnostic Methods EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jesus Diz Diaz

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
A strategy of primary prevention ICD implantation guided by cardiac magnetic resonance imaging: effect on appropriate therapies during follow-up
Doctor L. Cardelli (Lido Di Camaiore, IT)
Abstract Slides Video
Presentation thumbnail
Evolution of ECG after refractory out-of-hospital cardiac arrest
Doctor D. Kollin (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Achieving sub-millimetric bipolar resolution while retaining the clinical eye: the first bifocal clinical mapping array.
Mr Y. Abderrahman (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
ECG and anatomical features in patients of left coronary cusp ventricular arrhythmias with R wave in lead 1
Doctor S. Hara (Tsuchiura, JP)
Abstract Slides Video
Presentation thumbnail
Unravelling the cause of idiopathic ventricular fibrillation: diagnostic testing during follow-up
Ms R. Roodenburg (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnostic methods in ventricular arrhythmias (1)

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Prediction of ventricular arrhythmias in non-ischemic cardiomyopathy using a 12-lead ECG-based machine learning model
thumbnail
Congress Session
Risk prediction for ventricular arrhythmias: new tools for improved precision
thumbnail
Congress Presentation
Machine learning algorithms for predicting arrhythmic events in hypertrophic cardiomyopathy: limited enhancement beyond late gadolinium enhancement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources